Modulation of the immunological activation of human basophils by carbon monoxide.
Mirabella
C
C
Department of Preclinical and Clinical Pharmacology, University of Florence, Italy.
Ndisang
J F
JF
Berni
L A
LA
Gai
P
P
Masini
E
E
Mannaioni
P F
PF
D001491:Basophils / Q000187:drug effects* / Q000276:immunology*; D002248:Carbon Monoxide / Q000494:pharmacology*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006162:Guanylate Cyclase / Q000037:antagonists & inhibitors / Q000378:metabolism; D006419:Heme Oxygenase (Decyclizing) / Q000378:metabolism; D006427:Hemin / Q000494:pharmacology; D006636:Histamine Release / Q000187:drug effects; D006801:Humans; D010069:Oxadiazoles / Q000494:pharmacology; D010108:Oxyhemoglobins / Q000494:pharmacology; D011810:Quinoxalines / Q000494:pharmacology
C095284:1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one; D004791:Enzyme Inhibitors; D010069:Oxadiazoles; D010108:Oxyhemoglobins; D011810:Quinoxalines; D006427:Hemin; D002248:Carbon Monoxide; D006419:Heme Oxygenase (Decyclizing); D006162:Guanylate Cyclase